Trial intelligence / Profile preview

Robot/BTX Trial in Post-Stroke Upper Limb Spasticity

jRCTs062180094Completed

Start
May 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of botulinum toxin type A in Muscle spasm. Primary endpoint: Active elbow joint range of motion improvement. Started May 2017; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Muscle spasm

Beyond the preview

Go deeper on jRCTs062180094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs062180094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call